I took a small % in this but debated on posting. The ruling coming in two weeks on their big cancer pain drug, Onsolis. It will be do or die and I can bare the risk. Biotech bits hard, so you need to know that things can jump 40%+ either way, if the ruling goes good or bad. My "voices" as well as my "sources" say there is a 75% of it passing.
If passes, I believe the incremental revenue will be incredible and it's not priced in, allowing it to trade between $6 and $10. However, if it passes and they do an immediate share offering like XOMA, it will barely move (but I doubt this will happen).
Bottom line: It's a classic biotech lottery ticket, along with CTIC.
No comments:
Post a Comment